Accounting Manager (Remote)
The START Center for Cancer Research
Summary
The Manager, Accounting owns general accounting, the month-end close (MEC) and revenue accounting for the corporate entity and 10+ joint ventures, ensuring accurate, timely reporting on complex, multi-year clinical trial contracts.
Job description
Position Summary
The Manager, Accounting owns general accounting, the month-end close (MEC) and revenue accounting for the corporate entity and 10+ joint ventures, ensuring accurate, timely reporting on complex, multi-year clinical trial contracts.
Month-End Close and Financial Reporting
- Lead the monthly, quarterly and annual close, including journal entries, account reconciliations and flux analysis, and drive steady reductions in close time.
- Manage the close calendar and task assignments, track progress daily, escalate blockers early, and review staff work before it goes to the Controller or Director of Finance.
- Prepare and review financial statements, management reports and site-level analyses for leadership and joint venture partners.
Process Improvement and Scalability
- Design standardized, repeatable processes, reconciliation templates and close checklists that can be rolled out to new sites and joint ventures without adding headcount at the same rate.
- Identify and lead automation and system improvements in the ERP, billing and project accounting tools to reduce manual effort and close time.
- Document processes and train the team so the close runs consistently and staff can cover for each other.
Team Leadership
- Supervise, coach and develop accounting staff; set priorities, delegate effectively and hold the team to deadlines.
- Support the team through each month-end close by removing roadblocks, answering technical questions and stepping in where needed.
Compliance, Controls and Audit
- Maintain and improve internal controls over financial reporting, including SOX-style documentation and testing where applicable.
- Coordinate external audits, tax filings and quarterly reviews, and respond to auditor and lender requests.
- Manage multi-currency transactions, foreign subsidiaries and intercompany accounting, including revaluation and consolidation.
- Work with the tax team and outside advisors on VAT and transfer pricing.
Requirements
- Bachelor's degree in Accounting or Finance
- 8+ years of progressive accounting experience
- At least 2 years in a supervisory or management role
- Experience with month-end close, audits and consolidation across multiple entities
- Working knowledge of US GAAP and ASC 606
- CPA or equivalent license (preferred)
- Experience in a CRO, pharmaceutical, biotech, healthcare or other project-based services company (preferred)
- IFRS exposure (preferred)
- Demonstrated experience improving or building accounting processes in a growing company (preferred)
Benefits
- 401(k) Matching
- Annual Performance Bonus
- Paid Time Off
- Paid Holidays
- Medical, Dental & Vision
- Life Insurance
- Disability Insurance
- Employee Assistance Program
- Flexible FSA
- HSA Plans
Company overview
The START Center for Cancer Research (START) is a global leader in early-phase oncology clinical trials, providing specialized access to novel anti-cancer therapies through its extensive network of community-based research sites. Founded in Texas in 2007, START has established itself as the world's largest community-based early-phase oncology research organization with operations spanning the United States and Europe. The company operates 10 research locations globally and has conducted over 1,500 early-phase clinical trials, contributing to the development and approval of 45 FDA/EMA-approved cancer therapies. START's unique model embeds clinical trial capabilities within community oncology centers, enabling patients to access cutting-edge treatments where they already receive care. With more than 30 Principal Investigators and over 100,000 square feet of world-class research facilities, the organization focuses on accelerating the transition from clinical trials to approved treatments. START's comprehensive approach includes genetic tumor profiling, targeted therapies, and multi-specialty services, all delivered through a patient-centered framework that prioritizes accessibility and scientific rigor in cancer research.